The International Liver Congress 2018

11-15 April 2018
Paris, France

The International Liver Congress™ (ILC) is the annual meeting of the European Association for the Study of the Liver.



Date: Thursday, 12 April 2018 

Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: the STORM-C-1 phase II/III trial
*Andrieux-Meyer I, Salvadori N, Simon F, Cressey TR, Said RM, Hassan MRH, Omar H, Tee HP, Chan WK, Kumar S, Thongsawat S, Thetket K, Avihingsanon A, Khemnark S, Thanprasertsuk S, Piedagnel JM, Siva S, Asimah N, Da Silva N, Brenner J, Pécoul B, Lallemant M, Tan SS

* Presenting author 



More information: